succinylacetone has been researched along with mocetinostat in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
CastaƱeda, VL; Guzman, GS; Kinkade, JM; Parmley, RT; Pinnix, IB; Raju, SG | 1 |
McCormick, S; Nauseef, WM; Yi, H | 1 |
Bonkovsky, HL; Guzman, GS; Kinkade, JM; Pinnix, IB; Zaki, SR | 1 |
Kagan, VE; Keohavong, P; Yalowich, JC; Zheng, KC | 1 |
4 other study(ies) available for succinylacetone and mocetinostat
Article | Year |
---|---|
Ultrastructural, immunochemical, and cytochemical study of myeloperoxidase in myeloid leukemia HL-60 cells following treatment with succinylacetone, an inhibitor of heme biosynthesis.
Topics: Heme; Heptanoates; Histocytochemistry; Humans; Immunohistochemistry; Leukemia, Myeloid; Microscopy, Electron; Neutrophils; Peroxidase; Tumor Cells, Cultured | 1992 |
Roles of heme insertion and the mannose-6-phosphate receptor in processing of the human myeloid lysosomal enzyme, myeloperoxidase.
Topics: Brefeldin A; Cyclopentanes; Endoplasmic Reticulum; Glycosylation; Golgi Apparatus; Heme; Heptanoates; Humans; Immunosorbent Techniques; Kinetics; Lysosomes; Microscopy, Electron; Microscopy, Immunoelectron; Neutrophils; Peroxidase; Phosphorylation; Protein Precursors; Receptor, IGF Type 2; Tumor Cells, Cultured | 1992 |
The post-translational processing of myeloperoxidase is regulated by the availability of heme.
Topics: Cell Compartmentation; Cytoplasmic Granules; Heme; Heptanoates; Humans; Peroxidase; Porphobilinogen Synthase; Protein Processing, Post-Translational; Transcription, Genetic; Tumor Cells, Cultured | 1994 |
Increased mutant frequencies in the HPRT gene locus of leukemia HL-60 cells treated with succinylacetone.
Topics: Cell Survival; Heptanoates; HL-60 Cells; Humans; Hypoxanthine Phosphoribosyltransferase; Leukemia; Mutation; Peroxidase; Time Factors | 2006 |